This Novo Nordisk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• JP Morgan analyst Richard Vosser downgraded Novo Nordisk A/S (NYSE:NVO) from Overweight to Neutral. Novo Nordisk shares closed at $39.63 on Monday. See how other analysts view this stock.
• Morgan Stanley analyst Devin McDermott downgraded Cheniere Energy, Inc. (NYSE:LNG) from Overweight to Equal-Weight and slashed the price target from $258 to $236. Cheniere Energy shares closed at $223.35 on Monday. See how other analysts view this stock.
• Stifel analyst Stephen Willey downgraded Arcellx, Inc. (NASDAQ:ACLX) from Buy to Hold and cut the price target from $127 to $115. Arcellx shares closed at $113.75 on Monday. See how other analysts view this stock.
• Leerink Partners analyst Joseph Schwartz downgraded Gossamer Bio, Inc. (NASDAQ:GOSS) from Outperform to Market Perform and cut the price target from $6 to $1. Gossamer Bio shares closed at $0.4233 on Monday. See how other analysts view this stock.
• Barclays analyst Amos Fletcher downgraded Rio Tinto Group (NYSE:RIO) from Overweight to Equal-Weight. Rio Tinto shares closed at $97.67 on Monday. See how other analysts view this stock.

Considering buying NVO stock? Here’s what analysts think:

Photo via Shutterstock